IRIS
BOSSI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.094
NA - Nord America 5.592
SA - Sud America 1.644
EU - Europa 888
AF - Africa 166
OC - Oceania 7
Totale 16.391
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.425
US - Stati Uniti d'America 5.356
BR - Brasile 1.331
CN - Cina 1.031
VN - Vietnam 716
HK - Hong Kong 255
IT - Italia 253
IN - India 152
GB - Regno Unito 126
AR - Argentina 121
DE - Germania 116
MX - Messico 100
CA - Canada 99
BD - Bangladesh 86
FR - Francia 61
ZA - Sudafrica 58
TR - Turchia 56
ES - Italia 50
EC - Ecuador 49
ID - Indonesia 47
IQ - Iraq 44
PL - Polonia 42
JP - Giappone 38
RU - Federazione Russa 38
VE - Venezuela 35
CO - Colombia 34
UA - Ucraina 34
NL - Olanda 32
PK - Pakistan 30
UZ - Uzbekistan 29
MA - Marocco 28
CL - Cile 23
SE - Svezia 23
SA - Arabia Saudita 22
KE - Kenya 19
JO - Giordania 18
PY - Paraguay 18
TN - Tunisia 18
PH - Filippine 17
FI - Finlandia 15
NP - Nepal 14
UY - Uruguay 14
EG - Egitto 13
IE - Irlanda 12
AT - Austria 11
LT - Lituania 11
IR - Iran 10
MY - Malesia 10
TH - Thailandia 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 9
PE - Perù 9
TW - Taiwan 9
JM - Giamaica 8
OM - Oman 8
BE - Belgio 7
IL - Israele 7
AL - Albania 6
CH - Svizzera 6
DZ - Algeria 6
ET - Etiopia 6
RO - Romania 6
AM - Armenia 5
AU - Australia 5
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
GE - Georgia 5
HR - Croazia 5
RS - Serbia 5
AZ - Azerbaigian 4
BH - Bahrain 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
HN - Honduras 4
HU - Ungheria 4
LB - Libano 4
PS - Palestinian Territory 4
SN - Senegal 4
BB - Barbados 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GY - Guiana 3
PA - Panama 3
QA - Qatar 3
SR - Suriname 3
TT - Trinidad e Tobago 3
AO - Angola 2
BW - Botswana 2
GA - Gabon 2
GD - Grenada 2
LK - Sri Lanka 2
NG - Nigeria 2
NI - Nicaragua 2
PR - Porto Rico 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BZ - Belize 1
Totale 16.369
Salva come PNG Salva come JPEG
Città #
Singapore 2.218
San Jose 1.197
Ashburn 1.137
The Dalles 920
Shanghai 519
Dallas 488
Ho Chi Minh City 279
Beijing 237
Hong Kong 235
Hanoi 153
São Paulo 109
Seattle 86
Los Angeles 84
Santa Clara 66
Assago 62
New York 58
Orem 46
Johannesburg 41
Milan 40
Montreal 39
Rio de Janeiro 38
Boardman 37
Mexico City 35
Warsaw 35
Atlanta 34
Curitiba 34
Munich 32
Tokyo 31
Da Nang 30
San Francisco 29
Haiphong 28
Naples 28
Tashkent 28
Brooklyn 27
Council Bluffs 27
Campinas 26
London 26
Belo Horizonte 24
Chennai 24
Frankfurt am Main 24
Brasília 21
Buffalo 21
Chicago 21
Stockholm 21
Manchester 19
Guayaquil 18
Phoenix 18
Ribeirão Preto 18
Boston 17
Nairobi 17
New Delhi 17
Dhaka 16
Secaucus 16
Amsterdam 15
Denver 15
Quito 15
Baghdad 14
Mumbai 14
Poplar 14
Amman 13
Biên Hòa 13
Goiânia 13
Istanbul 13
Santiago 13
Toronto 13
Bogotá 12
Buenos Aires 12
Caracas 12
Chandler 12
Hải Dương 12
Porto Alegre 12
Tunis 12
Ankara 11
Dublin 11
Fortaleza 11
Karachi 11
Montevideo 11
Paris 11
Rome 11
Salvador 11
Charlotte 10
Helsinki 10
Bengaluru 9
Hillsboro 9
Jeddah 9
Santo André 9
Sorocaba 9
Vancouver 9
Asunción 8
Betim 8
Bến Tre 8
Cairo 8
Can Tho 8
City of London 8
Düsseldorf 8
Guarulhos 8
Jakarta 8
Kyiv 8
Madrid 8
Mauá 8
Totale 9.358
Salva come PNG Salva come JPEG
Nome #
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis 109
New trends in supportive care of head and neck cancers 105
Ectopic olfactory neuroblastoma is associated with increased frequency of syndrome of inappropriate antidiuretic hormone secretion and reduced disease control: Case series with systematic review and pooled analysis 92
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 85
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer 83
Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck 83
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 77
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology 73
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 73
A case of otoliquorrhoea secondary to immunotherapy response in head and neck cutaneous squamous cell carcinoma. When abrupt response may worry the physician 69
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 68
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 66
Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents 66
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial 65
USO DI MIRNA COME BIOMARCATORI PER LA DIAGNOSI E PROGNOSI DEL CARCINOMA ORALE A CELLULE SQUAMOSE 64
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 62
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study 62
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 59
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab 58
Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral Mucositis 58
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer 57
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 56
ESMO Guidelines: Cancer patient management during the COVID-19 pandemic 56
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 55
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 55
Computer Vision Foundation Models in Endoscopy: Proof of Concept in Oropharyngeal Cancer 54
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 53
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 53
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 53
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 53
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 53
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 51
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 51
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches 51
Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment 50
Editorial: Understanding and treating rare nasal and paranasal sinus cancers 50
Immune checkpoint inhibitor in high-risk oral potentially malignant disorders (IMPEDE study): An interim analysis on safety 50
The Use of Artificial Intelligence in Head and Neck Cancers: A Multidisciplinary Survey 50
Phase IV study on the use of benzydamine mouthwash in radiation-induced oral mucositis in patients with head and neck cancer 50
Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT) 50
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 50
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 49
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 49
Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods 49
Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework 49
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers 49
International, Multi-Institutional Evaluation of Practice Patterns and Outcomes for Recurrent and Metastatic Sinonasal Undifferentiated Carcinoma 48
Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know 48
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis 48
FURTHER IMPROVEMENT IN OUTCOMES OF NASOPHARYNGEAL CARCINOMA WITH OPTIMIZED RADIOTHERAPY AND INDUCTION PLUS CONCOMITANT CHEMOTHERAPY: AN UPDATE OF THE MILAN EXPERIENCE 47
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy 47
Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study) 47
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines 47
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 47
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia 47
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 46
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 46
The 2024 International Society of Oral Oncology-Multinational Association of Supportive Care in Cancer-American Society of Clinical Oncology guidelines for the prevention and management of osteoradionecrosis of the jaw 46
The use of fentanyl in pain management in head and neck cancer patients: a narrative review 46
Quality Assessment in Supportive Care in Head and Neck Cancer 46
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 45
Sinonasal Malignancies of Anterior Skull Base Histology-driven Treatment Strategies 45
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 45
Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: Consensus statements from an Italian expert panel 45
The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis 45
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 45
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up 45
Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group 45
A multidisciplinary approach to squamous cell carcinomas of the head and neck: What is new? 45
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? 45
Precision medicine in head and neck cancer: from immunotherapy to microbiota, circulating DNA and robotic surgery 45
Diving into hot topics of salivary gland carcinoma management—an EORTC young and early career investigator survey 45
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 45
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort 45
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? 44
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer 44
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements 44
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 44
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations 44
Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines 44
Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015 44
The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer. 44
Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding 44
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 44
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 44
A nationwide survey among emergency physicians and oncologists to improve the management of immune checkpoint inhibitors toxicity 44
Overview of oral potentially malignant disorders: From risk factors to specific therapies 43
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 43
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma 43
Acquired resistance to Hedgehog inhibitor through smoothened mutation in basal cell carcinoma 43
The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity 43
Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial 43
What to do and what not to do in the management of cancer pain: A physician survey and expert recommendations 43
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 43
Emerging tyrosine kinase inhibitors for head and neck cancer 42
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 42
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 42
The risk of recurrence in surgically treated head and neck squamous cell carcinomas: a conditional probability approach 42
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 42
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours 42
Totale 5.233
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 1 0 2
2021/20224 0 0 0 2 0 0 0 1 0 0 1 0
2022/202334 4 0 2 4 5 3 0 1 11 2 1 1
2023/20241.254 2 2 6 0 0 0 1 434 43 53 251 462
2024/20254.244 138 26 56 86 45 395 214 189 825 1.141 533 596
2025/202611.309 1.797 902 705 992 466 739 3.790 616 681 621 0 0
Totale 16.855